NO153573C - Analogifremgangsm¨te for fremstilling av terapeutisk aktiv e n-acylamino-alfa-arylacet-amidocefalosporiner. - Google Patents

Analogifremgangsm¨te for fremstilling av terapeutisk aktiv e n-acylamino-alfa-arylacet-amidocefalosporiner.

Info

Publication number
NO153573C
NO153573C NO753054A NO753054A NO153573C NO 153573 C NO153573 C NO 153573C NO 753054 A NO753054 A NO 753054A NO 753054 A NO753054 A NO 753054A NO 153573 C NO153573 C NO 153573C
Authority
NO
Norway
Prior art keywords
arylacet
amidocephalosporines
alfa
acylamino
preparation
Prior art date
Application number
NO753054A
Other languages
English (en)
Norwegian (no)
Other versions
NO753054L (fi
NO153573B (no
Inventor
Hirotada Yamada
Kousaku Okamura
Hisao Tobiki
Norihiko Tanno
Kozo Shimago
Takenari Nakagome
Toshiaki Komatsu
Akio Izawa
Hiroshi Noguchi
Kenji Irie
Yasuko Eda
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP49103183A external-priority patent/JPS5132576A/ja
Priority claimed from JP49108428A external-priority patent/JPS5136487A/ja
Priority claimed from JP49108429A external-priority patent/JPS5136488A/ja
Priority claimed from JP3382475A external-priority patent/JPS51108086A/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of NO753054L publication Critical patent/NO753054L/no
Publication of NO153573B publication Critical patent/NO153573B/no
Publication of NO153573C publication Critical patent/NO153573C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO753054A 1974-09-06 1975-09-05 Analogifremgangsm¨te for fremstilling av terapeutisk aktiv e n-acylamino-alfa-arylacet-amidocefalosporiner. NO153573C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP49103183A JPS5132576A (en) 1974-09-06 1974-09-06 Nn ashiruamino arufua ariiruasetoamidosefuarosuhorinruinoseiho
JP49108428A JPS5136487A (en) 1974-09-19 1974-09-19 Nn ashiruamino arufua ariiruasetoamidosefuarosuhorinrui no seizoho
JP49108429A JPS5136488A (en) 1974-09-19 1974-09-19 Nn ashiruamino arufua ariiruasetoamidosefuarosuhorinrui no seizohoho
JP3382475A JPS51108086A (en) 1975-03-20 1975-03-20 nn ashiruamino arufua ariiruasetoamidosefuarosuhorinruinoseizohoho

Publications (3)

Publication Number Publication Date
NO753054L NO753054L (fi) 1976-03-09
NO153573B NO153573B (no) 1986-01-06
NO153573C true NO153573C (no) 1986-04-16

Family

ID=27459847

Family Applications (1)

Application Number Title Priority Date Filing Date
NO753054A NO153573C (no) 1974-09-06 1975-09-05 Analogifremgangsm¨te for fremstilling av terapeutisk aktiv e n-acylamino-alfa-arylacet-amidocefalosporiner.

Country Status (15)

Country Link
US (1) US4156724A (fi)
AR (1) AR213728A1 (fi)
AT (1) AT347034B (fi)
CA (1) CA1074784A (fi)
CH (1) CH616682A5 (fi)
DD (1) DD122252A5 (fi)
DE (1) DE2539664A1 (fi)
DK (1) DK157246C (fi)
ES (3) ES440739A1 (fi)
FR (1) FR2283688A1 (fi)
GB (1) GB1510730A (fi)
HU (1) HU170897B (fi)
NL (1) NL7510486A (fi)
NO (1) NO153573C (fi)
SE (1) SE431211B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51115491A (en) * 1975-04-03 1976-10-12 Sumitomo Chem Co Ltd Method for preparing 77* *44hydroxyy1*5 naphthyridinee33carboxyamino ** phenylacetamido*cephalosporins
US4302454A (en) * 1976-03-03 1981-11-24 Sumitomo Chemical Company, Limited Cephalosporins
CH634848A5 (de) * 1976-08-17 1983-02-28 Fujisawa Pharmaceutical Co Verfahren zur herstellung neuer 7-(n-substituierter 2-phenylglycinamido)-3-substituierte-3-cephem-4-carbonsaeuren.
JPS545974A (en) * 1977-06-16 1979-01-17 Ajinomoto Co Inc Imidazoledicaroboxylic acid derivatives
JPS55139389A (en) * 1979-04-19 1980-10-31 Mitsui Toatsu Chem Inc Novel cephalosporin
JPS5572195A (en) * 1978-11-28 1980-05-30 Mitsui Toatsu Chem Inc Novel cephalosporin and antibacterial comprising it as active constituent
GB2045238B (en) * 1978-11-28 1982-12-01 Mitsui Toatsu Chemicals Cephalosporins
JPS55129287A (en) * 1979-03-27 1980-10-06 Ajinomoto Co Inc Imidazole-dicarboxylic acid derivative
US4267180A (en) * 1979-03-12 1981-05-12 Warner-Lambert Company Novel antibacterial amide compounds and process means for producing the same
US4311699A (en) * 1979-03-12 1982-01-19 Haskell Theodore H Aminoacid derivatives of cephalosporin compounds
JPS5643288A (en) * 1979-09-18 1981-04-21 Meiji Seika Kaisha Ltd Cephalosporin derivative and its preparation
US4288590A (en) * 1980-02-14 1981-09-08 Bristol-Myers Company 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates
CA1152489A (en) * 1980-03-05 1983-08-23 Takao Okuda ANTIMICROBIAL 7- (.alpha.-ACYLAMINO-.alpha.-ARYLACETAMIDO)-3- (SUBSTITUTED METHYL) CEPHALOSPORIN COMPOUNDS, THEIR COMPOSITIONS AND PRODUCTION THEREOF
JPS56158791A (en) * 1980-05-10 1981-12-07 Taisho Pharmaceut Co Ltd Cephalosporin compound
US4468394A (en) * 1981-04-02 1984-08-28 Eisai Co., Ltd. Cephalosporin compounds
US4404201A (en) * 1981-11-13 1983-09-13 Warner-Lambert Company Cephalosporins
ATE404537T1 (de) * 2002-08-13 2008-08-15 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA873869A (en) * 1971-06-22 Bristol-Myers Squibb Company Phenylacetic acid derivatives
US3634416A (en) * 1969-03-21 1972-01-11 Glaxo Lab Ltd Purification of 7alpha-aminoarylacetamido delta**3-4-carboxy-cephalosporins
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3634418A (en) * 1969-08-20 1972-01-11 Bristol Myers Co 3 - azidomethyl - 7-(alpha-aminophenyl(or thienyl)acetamido)ceph - 3 -em-4-oic acids
US3867380A (en) * 1971-02-18 1975-02-18 Smithkline Corp 3-Heterocyclic thiomethylcephalosporins
ZA728331B (en) * 1971-12-23 1974-06-26 Lilly Co Eli Preparation of 3-alkylthiomethyl cephalosporins
CA1076560A (en) * 1972-06-14 1980-04-29 Smith Kline And French Canada Ltd. 3-heterocyclic thiomethylcephalosporins
CA1003405A (en) * 1972-06-14 1977-01-11 Smith Kline And French Canada Ltd. P-hydroxymethylphenylacetamidocephalosporins
CA999574A (en) * 1972-06-14 1976-11-09 Smith Kline And French Canada Ltd. 7-hydroxyhalophenylacetamido-3-h heterocyclicthiomethyl cephalosporins
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
JPS5417754B2 (fi) * 1972-12-15 1979-07-02
CA1022544A (en) * 1972-12-21 1977-12-13 Yukiyasu Murakami Process of preparing a heterocyclic acyl group-substituted cephalosporin derivative
JPS5751837B2 (fi) * 1973-04-05 1982-11-04
GB1509074A (en) * 1974-04-05 1978-04-26 Yamanouchi Pharma Co Ltd Cephalosporin derivatives
CH606001A5 (fi) * 1974-05-13 1978-10-13 Ciba Geigy Ag
US3931160A (en) * 1974-05-15 1976-01-06 Smithkline Corporation α-Amino-α-(acylamidophenyl)acetamidocephalosporins

Also Published As

Publication number Publication date
ES456651A1 (es) 1978-07-01
DE2539664A1 (de) 1976-03-18
HU170897B (hu) 1977-09-28
ATA686375A (de) 1978-04-15
AT347034B (de) 1978-12-11
AU8461875A (en) 1977-03-17
SE431211B (sv) 1984-01-23
DK398375A (da) 1976-03-07
FR2283688A1 (fr) 1976-04-02
ES456652A1 (es) 1978-07-01
GB1510730A (en) 1978-05-17
US4156724A (en) 1979-05-29
AR213728A1 (es) 1979-03-15
NO753054L (fi) 1976-03-09
NO153573B (no) 1986-01-06
DD122252A5 (fi) 1976-09-20
CH616682A5 (fi) 1980-04-15
DK157246B (da) 1989-11-27
FR2283688B1 (fi) 1978-11-10
ES440739A1 (es) 1977-06-16
NL7510486A (nl) 1976-03-09
DE2539664C2 (fi) 1988-09-29
SE7509861L (sv) 1976-03-08
CA1074784A (en) 1980-04-01
DK157246C (da) 1990-05-07

Similar Documents

Publication Publication Date Title
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO153573C (no) Analogifremgangsm¨te for fremstilling av terapeutisk aktiv e n-acylamino-alfa-arylacet-amidocefalosporiner.
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO145240C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme o-substituerte 7beta-acylamino-3-cefem-3-ol-4-karboksylsyre-forbindelser
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO142173C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO141649C (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 7-fluorsubstituerte fenotiaziner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
NO144704C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.